omalizumab   Click here for help

GtoPdb Ligand ID: 6890

Synonyms: IGE25 | olizumab | R03DX05 | RG-3648 | rhumab-E25 | Xolair®
Approved drug Immunopharmacology Ligand
omalizumab is an approved drug (FDA (2003), EMA (2005))
Compound class: Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Peptide sequence analysis reveals that omalizumab is clone e25 in patent US5994511 [3].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: omalizumab

Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2003), EMA (2005))
International Nonproprietary Names Click here for help
INN number INN
8039 omalizumab
Synonyms Click here for help
IGE25 | olizumab | R03DX05 | RG-3648 | rhumab-E25 | Xolair®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 77
Other databases
GtoPdb PubChem SID 178103472
PubChem SID 178103472
Search PubMed clinical trials omalizumab
Search PubMed titles omalizumab
Search PubMed titles/abstracts omalizumab
Wikipedia Omalizumab